Author:
Luo Qingqing,Shen Fei,Zhao Sheng,Dong Lan,Wei Jianchang,Hu He,Huang Qing,Wang Qiang,Yang Ping,Liang Wenlong,Li Wanglin,He Feng,Cao Jie
Abstract
Abstract
Background
Long non-coding RNAs (LncRNAs) have been implicated as critical regulators of cancer tumorigenesis and progression. However, their functions and molecular mechanisms in colorectal cancer (CRC) still remain to be further elucidated.
Methods
LINC00460 was identified by differential analysis between human CRC and normal tissues and verified by in situ hybridization (ISH) and qRT-PCR. We investigated the biological functions of LINC00460 in CRC by in vitro and in vivo experiments. We predicted the mechanism and downstream functional molecules of LINC00460 by bioinformatics analysis, and confirmed them by dual luciferase reporter gene assay, RNA immunoprecipitation (RIP), RNA pull-down, etc.
Results
LINC00460 was found to be significantly overexpressed in CRC and associated with poor prognosis. Overexpression of LINC00460 promoted CRC cell immune escape and remodeled a suppressive tumor immune microenvironment, thereby promoting CRC proliferation and metastasis. Mechanistic studies showed that LINC00460 served as a molecular sponge for miR-186-3p, and then promoted the expressions of MYC, CD47 and PD-L1 to facilitate CRC cell immune escape. We also demonstrated that MYC upregulated LINC00460 expression at the transcriptional level and formed a positive feedback loop.
Conclusions
The LINC00460/miR-186-3p/MYC feedback loop promotes CRC cell immune escape and subsequently facilitates CRC proliferation and metastasis. Our findings provide novel insight into LINC00460 as a CRC immune regulator, and provide a potential therapeutic target for CRC patients.
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. The global. Regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of Disease Study 2017[J]. Lancet Gastroenterol Hepatol. 2019;4(12):913–33.
2. Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013[J]. Cancer Lett. 2017;401:63–71.
3. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. Cancer J Clin. 2016;66(2):115–32.
4. Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality[J]. Gut BMJ Publishing Group. 2017;66(4):683–91.
5. Siegel RL, Miller KD, Goding Sauer A et al. Colorectal cancer statistics, 2020[J]. CA: a Cancer Journal for clinicians, 2020, 70(3): 145–64.